Intralesional interleukin-2: A novel option to maximize response to systemic immune checkpoint therapy in loco-regional metastatic melanoma

Fingerprint

Dive into the research topics of 'Intralesional interleukin-2: A novel option to maximize response to systemic immune checkpoint therapy in loco-regional metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences